Safety and Efficacy of Apixaban For Therapeutic Anticoagulation in Critically Ill ICU Patients with Severe COVID-19 Respiratory Disease

Introduction  Despite the use of unfractionated heparin (UFH) or low molecular weight heparin (LMWH), rates of thromboembolic disease, and subsequent morbidity and mortality remain unacceptably high in patients with severe novel coronavirus disease 2019 (COVID-19) disease. Direct oral anticoagulants...

Descripción completa

Detalles Bibliográficos
Autores principales: Wenzler, Eric, Engineer, Monaz H., Yaqoob, Maidah, Benken, Scott T.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Georg Thieme Verlag KG 2020
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7685067/
https://www.ncbi.nlm.nih.gov/pubmed/33244512
http://dx.doi.org/10.1055/s-0040-1720962

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7685067/
https://www.ncbi.nlm.nih.gov/pubmed/33244512
http://dx.doi.org/10.1055/s-0040-1720962

Ejemplares similares